Device Vigilance

Device Vigilance - Axcellant

Device Vigilance

  1. lut 28, 2025

What Does 'Device Vigilance’ Mean?

Device vigilance refers to the systematic monitoring and evaluation of medical devices after they have been placed on the market. It involves the collection, analysis, and interpretation of data related to the safety and performance of medical devices throughout their lifecycle.

The primary goal of device vigilance is to identify and mitigate potential risks associated with the use of medical devices. This process includes reporting adverse events, tracking device malfunctions, and implementing corrective actions to ensure patient safety and maintain the quality of healthcare delivery.

Why Is the 'Device Vigilance’ Important in Clinical Research?

Device vigilance is crucial in clinical research as it ensures the ongoing safety and effectiveness of medical devices after they have been approved and released to the market. It provides a mechanism for researchers and healthcare professionals to continually assess and improve device performance based on real-world data and experiences.

In clinical trials, device vigilance helps researchers identify potential issues that may not have been apparent during initial testing phases. This information can inform future study designs, lead to product improvements, and ultimately enhance patient safety and treatment outcomes in clinical settings.

Good Practices and Procedures

  1. Implement a standardized adverse event reporting system with clear categorization and severity grading criteria
  2. Conduct regular post-market surveillance studies to proactively identify long-term device performance and safety trends
  3. Establish a cross-functional review board to assess vigilance data and recommend appropriate corrective actions
  4. Develop and maintain a comprehensive device history record, including software updates and component changes
  5. Conduct periodic user feedback surveys to capture qualitative data on device usability and potential issues

Related Terms

Resources

Axcellant Establishes Advisory Board to Strengthen Clinical and Strategic Leadership

Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…

One trial is no longer enough. Regulators on both sides of the Atlantic are building a new model of clinical evidence

The FDA and the European Commission are changing the rules of the game simultaneously. The shift is from a single…

Imaging Core Lab in Nuclear Medicine: Standardization, Quality Control, and Regulatory Alignment in Clinical Trials 

Modern nuclear medicine is a high-tech discipline that requires advanced facilities, infrastructure, qualified staff, and know-how. The reliable supply of radionuclides,…